The Valley Desk

NCT04408183 · Interventional trial

GLS-1200 Topical Nasal Spray to Prevent SARS-CoV-2 Infection (COVID-19)

Overall registry status Terminated

Phase 2

Conditions Infection, SARS-CoV 2

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov